BioSpace

BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial

The disclosure—which came ahead of a presentation of data from the Phase 1 Breakfree-2 study at the ACTRIMS-ECTRIMS meeting—follows Bristol Myers Squibb’s late summer revelation that it had paused certain trials of zolacabtagene autoleucel.

By BioSpace

1 min read
BMS reveals death from septic pneumonia of multiple sclerosis patient in CAR T trial
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights